Clinical Trial Update: NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating NT-proBNP-selected prevention of cardiac events in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Diseases
• Type 2 Diabetes Mellitus

Drugs mentioned

• NT-proBNP-selected prevention strategy

Snippet

Sponsor: Martin Huelsmann | Conditions: Heart Diseases, Diabetes Mellitus, Type 2 | Phase 4 | Status: RECRUITING